Home›Fingolimod›Fingolimod + Live Attenuated Vaccines

Does Fingolimod Interact with Live Attenuated Vaccines?

CDI records a contraindicated classification for Fingolimod and Live Attenuated Vaccines. The stored summary is: Avoid live attenuated vaccines during and for 2 months after fingolimod treatment due to risk of infection from immunosuppression. The mechanism involves fingolimod reduces immune response to vaccination. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.

Evidence status

A current label comparison is not yet available for this record. The summary and severity are stored CDI information; they have not been independently validated on this page against the exact product label.

Confirm the medicine, formulation, route, and applicable warning with your pharmacist or prescriber. Independent clinical review has not been recorded.

Saved label reference on DailyMed. This identifier has not been checked here as support for the current claim.

Stored CDI classification: Contraindicated
Fingolimod Class: Sphingosine 1-phosphate Receptor Modulator
Management: Confirm exact products with your pharmacist
Data Source: U.S. FDA via OpenFDA

Recorded Mechanism

Fingolimod reduces immune response to vaccination

What To Tell Your Doctor or Pharmacist

If you are taking Fingolimod and your doctor is considering prescribing Live Attenuated Vaccines (or vice versa), make sure to:

Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
Ask whether the benefits of combining these medications outweigh the risks for your specific situation
Ask what symptoms to watch for that would indicate the interaction is causing problems
Ask about alternative medications that do not interact with your current regimen
Ask how frequently you should be monitored while these are co-prescribed
Never stop or change either medication without first consulting your healthcare provider

💊 Fingolimod(Gilenya)+💊 Live Attenuated Vaccines(Ixchiq)

Severity & Interaction Details

⛔

contraindicated

Stored CDI classification: contraindicated

A current source comparison has not been recorded for this claim. The stored classification does not determine the clinical significance for your exact products or circumstances.

Severity scale

MinorContra

On record

Yes

Drug A class

Sphingosine 1-phosphate Receptor Modulator

Drug B class

—

Source

NLP:fingolimod

What this means in plain English

Avoid live attenuated vaccines during and for 2 months after fingolimod treatment due to risk of infection from immunosuppression.

About Fingolimod and Live Attenuated Vaccines

Fingolimod is a Sphingosine 1-phosphate Receptor Modulator. You may recognize them by the brand names Gilenya and Ixchiq.

Source and Limitations

This record was produced by automated extraction from drug-label information, including AI processing. The summary and mechanism are not verbatim FDA quotations. The drug profiles below may describe different formulations from the source label. Confirm the exact product and route with your pharmacist. This page does not establish independent clinical review.

📖 Source: NLP:fingolimod

Recent research & FDA safety updates

Live

Auto-aggregated from PubMed E-utilities and FDA safety data.

PubMed

Comparative effectiveness of ocrelizumab in subgroups of patients with multiple sclerosis: a multi-registry observational cohort study.about Fingolimod · 2026-05

PubMed

Investigating FTY720-NF immunomodulation of key lipid, gene, and protein mediators to enhance oral tissue regeneration.about Fingolimod · 2026-05

PubMed

Virus-induced epithelial lesions during fingolimod: HPV-related genital warts and molluscum contagiosum-case series and literature review.about Fingolimod · 2026-05

Share this result:

WhatsApp Text / SMS Email

Also share on:X Facebook

Add more drugs

Check Fingolimod and Live Attenuated Vaccines against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

How this information is prepared: CDI uses automated extraction, including AI, to summarize drug labeling from openFDA and includes separately identified curated-reference records. RxNorm helps identify medications; it does not verify interaction claims. Extracted summaries and CDI severity classifications can contain errors and are not verbatim FDA statements or independent clinical review. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.